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Neurotoxicity with persistent unilateral ophthalmoplegia from envenoming by a 
wild inland taipan (Oxyuranus microlepidotus, Elapidae) in remote outback South 
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3Intensive and Critical Care Unit, Flinders Medical Centre, Bedford Park, South Australia 5042; 
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A case of life threatening envenoming by a wild specimen of the inland taipan, 
Oxyuranus microlepidotus, is described. There have been 11 previously well-
documented envenomings by O. microlepidotus, but only 2 were inflicted by wild 
snakes. Envenomed patients have presented predominantly with defibrinating 
coagulopathy and neurotoxicity.  
Case Report 
The victim was seeking to observe members of an isolated population of this 
species and was envenomed while attempting to photograph an approximately 
1.5 m specimen. He reported feeling “drowsiness” and blurred vision that 
                                                        














progressed to ptosis; he later developed dysphagia and dysarthria. The patient 
was treated with 1 vial of polyvalent antivenom, which was later followed with 
an additional two vials of taipan monovalent. He was intubated during retrieval, 
and recovered after 3 days of intensive care. He had a right ophthalmoplegia that 
persisted for approximately 1 week post-envenoming. Despite a positive 20-
minute whole blood clotting test, defibrination coagulopathy was absent, and 
there was no myotoxicity, or acute kidney injury.  
Discussion 
Physicians presented with a patient envenomed by O. microlepidotus should 
remain cognizant of the possible variability of medically important venom toxins 
in some populations of this species. Some patients seriously envenomed by this 
species may develop persistent cranial nerve palsies. When clinically indicated, 
prompt provision of adequate antivenom is the cornerstone of managing O. 
microlepidotus envenoming. Rapid application of pressure-bandage 
immobilization and efficient retrieval of victims envenomed in remote locales, 
preferably by medically well-equipped aircraft, probably improves the likelihood 
of a positive outcome. 
 
Introduction 
The genus Oxyuranus contains 3 species of highly venomous elapid snakes. Of 
these, the coastal taipan (O. scutellatus) has been most medically important, 
although in comparison to the early Twentieth Century, is now a less common 
cause of serious envenoming in Australia. However, the Papuan taipan, O. s. 
canni, has major medical importance in Papua New Guinea. It is noteworthy that 














impression is probably based on a single study (Wüster et al. 2005) that 
investigated several mitochondrial DNA sequences derived from a single 
specimen of O. scutellatus, and from two specimens of O. s. canni. Wüster et al. 
(2005) appropriately indicated that for several reasons (e.g. the limited sample 
size), further investigation would be necessary in order to confirm synonymy of 
O. s. canni with O. scutellatus. We agree, and although their synonymy may soon 
be confirmed, we prefer to reference the subspecies until further supporting 
evidence is published.  
There have not yet been any documented envenomings by the newly discovered 
western desert taipan, O. temporalis. The inland taipan, Oxyuranus 
microlepidotus, attains an average adult length of 1.5 m, and occurs in remote 
inland regions of channel country (south-western Queensland with extension 
into sections of north-eastern South Australia and north-western New South 
Wales) and surrounding areas of dunes, as well as gibber plains (or, ‘stony 
downs’, flat, pebble/stone-covered plains) near the junction of Queensland, New 
South Wales and South Australia (Mirtschin et al., 2017). Oxyuranus 
microlepidotus venom is well known for having the so far highest experimental 
lethal potency (subcutaneous LD50 0.025 mg/kg; Broad et al., 1979) of any tested 
snake venom. However, experimental venom lethal potency tested in mice 
doesn’t reliably predict medical risk, and there have been no fatalities among the 
handful of patients seriously envenomed by O. microlepidotus (Mirtschin et al., 
2017). Most patients  envenomed    by    O.    microlepidotus    have    presented 
with defibrinating coagulopathy and neurotoxicity. 
We report here a case of an O. microlepidotus envenoming that caused 














The case also highlights some of the difficulties that may be encountered when 
assessing a victim bitten by a highly venomous snake in a remote location. 
 
Clinical Record 
A 28 yr old male professional snake catcher sought to photograph a specimen of 
inland taipan (O. microlepidotus) in a location (north of Coober Pedy, South 
Australia; 526 miles north of Adelaide; general regional coordinates: 29.0139° 
South, 134.7533° East) known to have a possibly isolated population of this 
species.  An approximately 1.5 m specimen of O. microlepidotus was found 
(photographs of the specimen have been reviewed and the taxon verified by the 
senior author) in late afternoon (at about 1730 hours), and carefully positioned 
for photography by the victim. The snake moved away from the selected site, and 
the victim gently pulled the snake back by the tail. The snake ‘looped’ backwards, 
and the victim re-positioned it by turning it while maintaining the grip on its tail. 
As the victim’s companion prepared to take the photo, the victim noted that he 
was bleeding from the right forearm, and understood that he had been grazed or 
‘raked’ by a glancing bite or single fang scratch. Within a few minutes he felt 
nauseated, light-headed and stated that he felt “drowsy”; he and his companion 
promptly applied a pressure-bandage immobilization (PBI) then sought help at a 
nearby hospital. It should be noted that the area is serviced by community and 
family physicians, and has no intensive care facilities. Critically ill patients are 
moved by a statewide specialist medical retrieval service to a tertiary referral 
hospital in the state’s capital city (a 2hr flight to the south). 
The victim was evaluated approximately 45 minutes after the bite, and the 














(MedSTAR) who then contacted the on-call toxinologist (SAW).  At 
approximately one hour post-envenoming, the patient began vomiting, and 
reported increasingly blurred vision; early bilateral ptosis and slurred speech 
were noted, but there was no evidence of respiratory compromise. Given the 
local unavailability of formal laboratory services, a 20-minute whole blood 
clotting test (20WBCT) was performed in a glass tube and remained non-clotted 
after 25+ minutes, a ‘positive’ result suggesting the presence of coagulopathy. 
Because of the limited clinical personnel in the Coober Pedy local hospital, 
urgency of the patient’s condition and process of arranging retrieval, a blood 
sample from a healthy volunteer was not tested as a 20WBCT control sample. 
Two hours after the envenoming, one vial of Polyvalent snake antivenom 
(Seqirus®, Melbourne, VIC, Australia; contains 12000 in vitro neutralizing units 
for O. scutellatus venom; this is equal to the neutralizing capacity of monospecific 
taipan antivenom) was administered IV to the patient, and a two-stage air 
retrieval from Coober Pedy was arranged. The Polyvalent antivenom infusion 
was completed, and the patient departed with the first aircraft 3.5 hours after 
the ‘bite’. In order to slow the uptake of any possible sequestered venom, the PBI 
was intentionally left in place during the entire retrieval process. As the patient 
was transferred from the first to the second aircraft mid-retrieval (5 hours after 
the envenoming), his vital signs remained within normal limits, but he was 
unable to significantly crease his forehead, exhibited progressive dysarthria, 
dysphagia with increasing drooling, and severe ptosis. In light of this 
progression, the patient was given rocuronium, intubated, ventilated and 
provided with an additional two vials of Taipan antivenom (Seqirus®, 














vitro neutralizing units for O. scutellatus venom), 5.5 hours post-bite. The 
retrieval was further complicated by an aircraft malfunction necessitating 
transfer to a third aircraft.  
After arrival at the tertiary medical center, 10.3 hours post-bite, formal 
laboratory investigations revealed no evidence of coagulopathy including an 
absence of elevated D-dimer.  Aside from a transiently elevated C-reactive 
protein (60 mg/L, peaked approximately 40-42 hr post-envenoming; likely 
related to moderate local inflammation at the wound site), all laboratory 
investigations remained within normal limits, as did the patient’s vital signs. He 
remained intubated for 48 hours, and exhibited ptosis, as well as 
ophthlamoplegia post-extubation. Deep tendon reflexes were reduced (1+) in 
upper and lower extremities. Both pupils reacted sluggishly, but his right pupil 
appeared qualitatively more so; the patient was unable to tolerate 
comprehensive testing of his right eye, and exhibited right-sided photophobia. 
He complained of nausea and growing ocular fatigue with further attempted 
examination/testing. He was discharged five days after admission with a 
persistent right ophthalmoplegia; ophthalmological and neurological 
examination prior to discharge was otherwise unremarkable. The patient 
reported a full recovery 7 days after the envenoming. 
 
Discussion 
Approximately 11 bites and/or envenomings by O. microlepidotus have been 
reported (only 2/11 were inflicted by wild specimens) (Trinca, 1969; Mirtschin 
et al., 1984; Covacevitch et al., 1995; White et al., 1992; Smith and Ambikapathy, 














this species have also occurred. Almost all of the previously documented patients 
presented with defibrination coagulopathy, most also had paralysis, and at least 
one had myotoxicity. Our patient only developed neurotoxicity, that manifested 
as delayed descending flaccid paralysis commencing with cranial nerve 
involvement about 1 hour post-bite, then progressing approximately 4-5 hours 
post-bite.   
The results of a 20WBCT suggested coagulopathy, but instrumented testing 
about 9 hours later did not find any fibrin-split products, and the aPTT and INR 
were normal.  Relevantly, Smith and Ambikapathy (1992) reported an O. 
microlepidotus envenoming that featured persistent neurotoxicity with a 
prolonged aPTT, thrombocytopenia and giant platelets. Their patient received 
one vial of Polyvalent antivenom, and the aPTT returned to normal 4 hours later; 
the fibrin split products remained within normal limits, but the 
thrombocytopenia remained abnormal for 10 days. They did not specifically 
mention the INR, or fibrinogen, although omission of the INR may have been due 
to the mixed use of the term at that time because ‘INR’ was standardized after re-
assessment of the International Sensitivity Index (ISI) in 1983 (WHO, 1983), and 
for several years thereafter its standardization was discussed or reviewed by 
several authors  (e.g. see Hirsh et al., 1989). Thus, the report by Smith and 
Ambikapathy (1992) is difficult to interpret because it could suggest a possible 
transient anticoagulant coagulopathy with thrombocytopenia and altered 
platelet morphology. In a recent study of 33 patients systemically envenomed by 
Oxyuranus spp., 31 (93%) developed defibrinating coagulopathy and the median 
time for the INR to decrease to less than 2.0 was 12.3 hours (IQR: 12.3–18.7 














that D-dimer has a half-life of approximately 15 hours (Rühl et al., 2015). Smith 
and Ambikapathy (1992) speculated that the venom had a “direct marrow 
effect”, but their report contains no further information to support their 
hypothesis. Therefore, the possibility that our patient developed a transient 
anticoagulant coagulopathy cannot be excluded. However, given the clinical 
evidence in our case and other well-documented O. microlepidotus envenoming, 
in our opinion a false positive 20WBCT is more likely. The 20WBCT is commonly 
used globally in the rural tropics where medical laboratories may be difficult to 
access, and has certainly been a useful test in a variety of clinical settings (e.g. see 
Sano-Martins et al., 1994; Gaus et al. 2013; Iliyasu et al., 2015). However, the 
assay has variable sensitivity and specificity and thus can yield false negatives or 
positives under some clinical circumstances (Isbister et al., 2013; Ratnayake et 
al., 2017). In Australian rural settings without laboratory instrumentation it may 
be the only option, but in our case the available evidence suggests that it 
probably yielded a false positive, as has been occasionally noted after 
coagulopathic envenoming from some Australian elapids (White, 2013). It 
should be stressed that failure of the 20WBCT may often be due to “operator 
error” (e.g. extent of training of personnel performing the test, assay 
temperature, use of incorrect test vessels, misinterpretation of results, etc.; 
Isbister et al., 2013; Auerbach et al., 2016; Ratnayake et al., 2017).  
It is also noteworthy that although our patient had correctly applied a PBI within 
a few minutes after contact with the taipan, he developed signs and symptoms of 
systemic envenoming in less than 30 minutes. While it is possible that early 
provision of antivenom prevented a more rapidly progressive paralysis, 














aforementioned series of Oxyuranus spp. envenoming, Johnston et al. (2017) 
reported 7 bites by captive O. microlepidotus; 6 patients were envenomed, and 
these all received antivenom. All developed consumption coagulopathy, 57% had 
neurotoxicity, and 43% had an acute kidney injury (AKI) and/or 
microangiopathic hemolytic anemia (MAHA); none developed myotoxicity 
(Johnston et al., 2017). 
Studied samples of O. microlepidotus venom contain paradoxin, which is closely 
similar to taipoxin, the heteropentameric presynaptic neurotoxin described from 
coastal taipan (O. scutellatus) venom, several postsynaptic neurotoxins, 
procoagulants that function as Va and Xa homologues, myotoxic phospholipases 
A2, natriuretic peptides, and numerous other components (Fohlman, 1979; 
Hamilton et al., 1980; Bell et al., 1988; Crachi et al., 1999; Fry et al., 2005; Clarke 
et al., 2006; Vink et al., 2010; Earl et al., 2012). Venom composition variability 
has been thoroughly documented in several medically important viperids and 
elapids (e.g. Minton and Weinstein, 1986; Chippaux et al., 1991). It is probable 
that the specimen that envenomed our patient secreted venom that either 
lacked, or contained much lower concentrations, of several medically important 
toxins (procoagulants) commonly found in most tested venoms of this taxon. 
Johnston et al. (2017) asserted that one vial of antivenom “should be sufficient to 
treat most taipan envenoming because all of the detectable venom antigens were 
bound by antibody present in one vial of antivenom”.  This view has been 
previously criticised (Weinstein et al., 2016) because of problems and pitfalls of 
the methods (ELISA assays) used to support their recommendations. Treatment 
must be provided per individual patient with consideration for their co-














ultimately, one “size” does not necessarily “fit all”. Coastal taipan (O. scutellatus) 
envenoming can rapidly (in several minutes) clinically progress after removal of 
the PBI (Southern et al., 1996; SAW, personal observations), and thus it is 
essential to initially provide adequate antivenom, as clinically indicated. 
The persistence of a unilateral ophthalmoplegia in this case is uncommon and 
not readily explained, as venom paralytic effects are typically bilateral because of 
the systemic distribution of venom, a non-systemic exception being localised 
effects from paralysis ticks attached close to a cranial nerve (White, 1995). 
Delayed resolution of bilateral ptosis and partial ophthalmoplegia does occur in 
some patients who develop paralytic features after Australian elapid 
envenoming and longer term residual hyposmia or anosmia also may occur, and 
not always in association with neurotoxic envenoming (Sutherland and Tibballs, 
2001; White, 2010; 2013; Sethi et al., 2017). A patient seriously envenomed by a 
common tiger snake (Notechis scutatus, Elapidae) experienced a similarly 
persistent unilateral (left) ophthalmoplegia that lasted for at least ten months 
and did not fully resolve (lost to follow-up after one year; SAW personal 
observations). Although it is speculative to consider possible causes of these 
patients’ persistent unilateral ophthalmoplegia, it is noteworthy that it may 
present in patients with internuclear ophthalmoplegia (INO) that arises from an 
interruption of fibres connecting the oculomotor nuclei, and can be unilateral or 
bilateral (Karski et al., 2013). Unilateral INOs are most commonly associated 
with ischaemia (Kaski et al., 2013). Unilateral ophthalmoplegia also has been 
rarely reported in other disease states such as acute myeloid leukemia (Mott and 
Carlson, 2012), ophthalmoplegic migraine (Patel et al., 2015), and occasionally 














In conclusion, we have described a serious envenoming inflicted by a wild O. 
microlepidotus that featured progressive neurotoxicity and without defibrinating 
coagulopathy. Management of our patient emphasized several important 
observations: the 20WBCT may give false positive results and must be 
considered together with clinical observations of the patient; prompt and correct 
application of PBI may delay onset of venom effects; early administration of 
antivenom may provide a clinically important window for successful patient 
retrieval from remote locations; prompt intubation and airway protection should 
be performed whenever possible, as clinically needed, especially during 
retrievals from remote locales; some populations of O. microlepidotus may 
produce venom without clinically significant levels of defibrinating 
procoagulants, and possibly with anticoagulant components; clinically indicated 
antivenom should be administered as early as possible when medically feasible, 
and the dose should be based on the severity of the individual patient’s 
envenoming, as well as the patient’s therapeutic response. 
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Neurotoxicity with persistent unilateral ophthalmoplegia from envenoming by a 
wild inland taipan (Oxyuranus microlepidotus, Elapidae)  




• Documentation of a serious envenoming by a wild inland taipan 
(Oxyuranus microlepidotus) in the remote Australian outback 
• Defibrinating coagulopathy was absent; a 20 minute whole blood clotting 
test may have been a false positive, or possibly indicated a transient anti-
coagulant coagulopathy 
• The patient developed progressive neurotoxicity; had a complicated 
retrieval from the outback; was ultimately treated with Polyvalent and 
Taipan monospecific antivenom 
• An initial bilateral ophthalmoplegia was notably more pronounced on the 
right side, and persisted as a unilateral right sided ophthalmoplegia 
• Full recovery achieved after 1 week 
 
